Coping With Shortages of Mounjaro and Wegovy

As many of our GLP-1 patients know, the U.S. faces a significant shortfall in the supply of GLP-1 agonist medications, including Wegovy and Mounjaro. This webpage aims to guide you through this challenging period.

Your Options in the GLP-1 Drug Shortage

1. Exploring Different Pharmacies:

   • Retail Pharmacy Brands: Remember, different pharmacies face distinct challenges. While Walgreens may be low on stock, CVS or Walmart might have a surplus. Don't hesitate to shop around.

   • Chain vs. Local Pharmacies: While national chains dominate, Albuquerque boasts several outstanding independent pharmacies. Don't overlook these local gems when searching for GLP-1 drugs.

   • Mail Order Pharmacies: Their stock levels might differ from those of retail pharmacies. It’s worth investigating.

2. Drug-Specific Availability: Emergency Switching

   Note on Mounjaro's Use for Diabetes: Mounjaro is officially sanctioned only for Type-2 diabetes treatment. Its weight loss variant is on the brink of FDA approval. However, some pharmacies prioritize diabetic patients due to the immediate health risks posed by diabetes.

​

Saxenda:

Less popular and generally seen as less effective, Saxenda may be a potential short-term substitute. Contact us at Holland Clinic if you want to consider this option.

​

Wegovy (semaglutide):

While it's the preferred GLP-1 weight loss drug for many, its availability is dwindling. Still, it might be a temporary alternative for Mounjaro users.

​

Mounjaro:

Widely used for weight loss, even though it's not FDA-approved for that purpose. Its availability might fluctuate, so keep an eye out.

​

Dosage Variations:

Sometimes, only specific dosages are scarce. If needed, we might adjust your dosage, but do note that rapid dosage escalation can result in side effects like nausea.

 

Alternative Treatments:

If GLP-1 drugs remain elusive, we offer the option to transition temporarily to our conventional weight loss medication regimen.

On Compounded GLP-1 Drugs: We prioritize your safety. While 'compounded' versions exist, we advise STRONGLY against them due to potential serious risks.

​

Patience

It's crucial to remember that this shortage, though frustrating, will pass. Obesity is a long-term condition requiring sustained treatment. Temporary interruptions, however inconvenient, won't significantly impact your long-term journey. Rest assured, I'm committed to supporting all my GLP-1 patients during this period.

Stay informed and resilient,

Dr. Mark J. Holland